Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of TNNT2 mRNA | increases expression | 20713471
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TNNT2 mRNA | affects expression | 16483693
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of TNNT2 mRNA | increases expression | 14729362
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of TNNT2 mRNA | affects expression | 17484886
|
C016299 |
chelerythrine |
chelerythrine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of TNNT2 protein] | decreases reaction|increases phosphorylation | 12003851
|
D004317 |
Doxorubicin |
[Doxorubicin co-treated with MT2A protein] results in increased expression of TNNT2 protein | affects cotreatment|increases expression | 16144979
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of TNNT2 protein | decreases expression | 16144979
|
D004317 |
Doxorubicin |
Doxorubicin results in increased secretion of TNNT2 protein | increases secretion | 17382496
|
D004317 |
Doxorubicin |
Zinc inhibits the reaction [Doxorubicin results in increased secretion of TNNT2 protein] | decreases reaction|increases secretion | 17382496
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of TNNT2 protein | decreases expression | 17924179
|
D004317 |
Doxorubicin |
EPO protein inhibits the reaction [Doxorubicin results in decreased expression of TNNT2 protein] | decreases expression|decreases reaction | 17924179
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of TNNT2 mRNA | increases expression | 17616710
|
D010795 |
Phthalic Acids |
Phthalic Acids affects the expression of TNNT2 mRNA | affects expression | 15728792
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of TNNT2 protein | decreases expression | 20130022
|
D013755 |
Tetradecanoylphorbol Acetate |
chelerythrine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of TNNT2 protein] | decreases reaction|increases phosphorylation | 12003851
|
C025643 |
vinclozolin |
vinclozolin affects the expression of TNNT2 mRNA | affects expression | 19015723
|
D015032 |
Zinc |
Zinc inhibits the reaction [Doxorubicin results in increased secretion of TNNT2 protein] | decreases reaction|increases secretion | 17382496
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.71 | 18287403 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.56 | 17190629 16889938 17202136 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.59 | 17418594 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.67 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
2.77 | 17119284 16325427 16410023 16580781 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
5.03 | 16916123 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.73 | 19015723 |
MESH:D001249 |
Asthma |
|
Zinc |
2.98 | 17085522 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Phthalic Acids |
4.43 | 20106747 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.15 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.87 | 14601052 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.83 | 17109824 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.91 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
2.00 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.00 | 17983394 15567936 16096432 17426702 17369602 16115903 18628466 15692762 19526202 18234424 16322301 15994142 18695136 18382427 11325840 15939500 15136595 16264153 16826403 15668708 15993339 16935488 15634643 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.00 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.92 | 16192424 16227642 15721981 16124888 16050911 16011737 10355542 15673190 3786805 18705752 15700767 16097048 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.98 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
3.20 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.20 | 17876044 16234567 18059187 16023760 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.20 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.92 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
7.92 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
7.92 | 16543248 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18850075 16120746 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.60 | 16269455 16455267 16278810 17007740 16109756 16242529 17974986 17329180 17382496 17131338 15505089 16612575 15792986 16731534 15811867 18627295 17924179 16651473 17928571 17308081 16952015 17351982 16364871 17519947 15476868 |
MESH:D002311 |
Cardiomyopathy, Dilated |
marker/mechanism |
|
| 19477965 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.98 | 17334414 16243910 |
OMIM:115195 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2 |
marker/mechanism |
|
| |
OMIM:612422 |
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3 |
marker/mechanism |
|
| |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.73 | 16936243 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 16354765 12621046 8697196 15340226 15668235 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.70 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
2.70 | 19302082 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.47 | 14966744 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
4.30 | 16479319 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
6.41 | 6884620 15968718 17522070 7120509 10092053 9327722 10915739 6623471 19085960 3786805 21278145 15998439 2869522 11566570 7179309 19336974 4309450 3732212 7440962 16227642 15027814 16177239 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.41 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.41 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.38 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.38 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.32 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
7.32 | 8273558 16716910 9599246 8113982 7812673 11698051 15177302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 16714409 15322242 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.52 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.33 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
5.00 | 15264214 15623463 16510608 16805852 16704527 15878914 15547721 15547733 15150132 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
5.00 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
3.28 | 16239168 12631006 15959796 61145 17595544 12795759 16045604 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.74 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
9.06 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.06 | 20067830 |
MESH:D005756 |
Gastritis |
|
Zinc |
4.97 | 17241300 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.09 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.47 | 16417039 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.42 | 17150277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
4.03 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.60 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.38 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.56 | 17875725 14766674 18006777 16495754 16330681 16244372 16879835 17888722 16707910 12587719 16144979 16244371 18674790 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.66 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Zinc |
7.66 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.94 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.65 | 17241300 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.01 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.72 | 19900420 19110552 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.83 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.50 | 17606976 15147373 18501091 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 18606429 8697196 15340226 16959395 16354765 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.69 | 16899240 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.94 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.23 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.11 | 16467254 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.34 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
5.34 | 15177302 7562506 8273558 11698051 7812673 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.77 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.67 | 15699352 15369732 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
6.67 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
10.55 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
10.55 | 16518626 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.33 | 16085563 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.89 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.86 | 17157831 21278145 11408273 16239168 11903743 16221502 16943688 17174718 17334410 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.56 | 18420326 15370692 17565644 12546737 15925388 18418968 16027843 15730626 16033810 15818738 15650968 14512876 12389079 12898905 15893842 17525996 18395095 17557913 12649538 12667390 14748882 17766677 10355542 17714472 15931870 15673190 14724832 12445421 18263696 16192424 16097048 18412020 17922224 17761835 18429990 13678700 14716496 17631135 12666154 17805973 16011737 17640975 17900296 18210741 12586293 18395914 17976157 18187930 15123356 18156304 18054572 12632512 15052691 16248980 17721639 15876570 18472332 17708605 16015684 12958196 12741479 15338365 15362042 18251166 15959796 18376398 11481614 17823541 18481824 12632514 18339082 18166357 17869086 12445418 18472094 14716833 18205269 16136751 18277467 20821823 17481882 18279442 18006644 17944888 18317297 15996030 18705752 15057751 16116963 16638106 17698563 12609069 14620537 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.56 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.56 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.10 | 16246199 15830285 16964402 17285989 15720792 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.30 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.79 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
4.52 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.52 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
10.24 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
10.24 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.24 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.58 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.58 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
3.58 | 11807781 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.54 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.88 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.70 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
14.97 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
14.97 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
14.97 | 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
14.97 | 12773700 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.30 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.10 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.61 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.94 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.99 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
marker/mechanism |
|
| 10789933 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.99 | 18259882 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.91 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.10 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.31 | 15555623 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.20 | 15930896 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
3.17 | 15976015 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.43 | 12065085 8330346 18404319 18922899 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.33 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.33 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
4.26 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.01 | 11118676 11896295 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
10.01 | 19015723 18042343 18220299 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.09 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.57 | 16729912 15897917 15749863 18437689 16888761 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
3.57 | 16517595 12429649 16606632 16700911 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.09 | 18629315 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.36 | 17922066 |
MESH:D012127 |
Respiratory Distress Syndrome, Newborn |
marker/mechanism |
|
| 10789933 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
4.21 | 16584753 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.09 | 16767912 17203757 17710206 15675481 15625365 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.37 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.94 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
14.01 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
14.01 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
14.01 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
14.01 | 8985016 18404319 8330346 11807781 12065085 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.70 | 16767912 17203757 15625365 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.32 | 12958204 17575124 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.45 | 16010429 17909728 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
4.50 | 16543248 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.80 | 17653716 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.36 | 17638931 16364871 17678736 17334414 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |